Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STX18 intronic transcript 1 (STX18-IT1) is a long non-coding RNA gene located within an intronic region of the STX18 gene on chromosome 4 (4p16) and does not encode a protein[1][7]. STX18-IT1 functions predominantly as a regulatory RNA molecule involved in cardiac development, particularly in the differentiation of cardiomyocytes from embryonic stem cells[2][6]. Its precise mechanism includes influencing the expression of critical cardiac transcription factors such as NKX2-5, ISL1, GATA4, and TBX5 during development[2][6]. Genetic studies have identified three single nucleotide polymorphisms (SNPs; rs870142, rs16835979, and rs6824295) in the locus of STX18-IT1 that are strongly associated with increased risk for atrial septal defect (ASD), a common congenital heart defect[2][6]. Knockdown of STX18-IT1 impairs cardiac mesoderm specification and reduces the efficiency of cardiomyocyte differentiation[2][6]. There is no evidence that STX18-IT1 directly interacts with drugs or is a direct therapeutic target; rather, it serves as a disease-associated regulatory RNA and potential biomarker for developmental cardiac disorders[2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STX18 intronic transcript 1 (STX18-IT1).